ACAAI Video Pearls

<乌鸦传媒 class="page-description">Video Pearls from the American College of Allergy, Asthma & Immunology

"A lot of areas in which we're going to see a lot of improvements," says Michael E. Wechsler, MD

<乌鸦传媒 class="section_title">Latest ACAAI Video Pearls Meeting Coverage

Improved provocation test outcomes and symptom control in phase II study

November 25, 2024

Phase II study shows reductions of 75% and 77% in attack rates with 25- and 50-mg doses

November 18, 2024

Innovative pathways through targeted therapies, advanced imaging, and multifaceted goals

November 11, 2024

<乌鸦传媒 class="section_title"> Latest Allergy & Immunology Meeting Coverage